GOSSGossamer Bio Inc
GOSS
Gossamer Bio Inc2,966
Mkt Cap
$94.02MVolume
3.17M52W High
$3.8752W Low
$0.32PE Ratio
-0.53GOSS Fundamentals
Price
$0.4184Prev Close
$0.4006Open
$0.407750D MA
$0.9867Beta
2.21Avg. Volume
13.71MEPS (Annual)
-$0.7455P/B
-0.76Rev/Employee
$299,203.70$774.38
CLASS ACTION NOTICE: Berger Montague Advises Gossamer Bio, Inc. (NASDAQ: GOSS) Investors to Inquire About a Securities Fraud Class Action
CLASS ACTION NOTICE: Berger Montague Advises Gossamer Bio, Inc. (NASDAQ: GOSS) Investors to Inquire About a Securities Fraud Class Action CLASS ACTION NOTICE: Berger Montague Advises Gossamer Bio...
PR Newswire·24h ago
GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026
GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 PR Newswire NEW YORK...
PR Newswire·2d ago
Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud...
PR Newswire·4d ago
Shareholders who lost money in Gossamer Bio, Inc (NASDAQ: GOSS) Should Contact Wolf Haldenstein Immediately
Shareholders who lost money in Gossamer Bio, Inc (NASDAQ: GOSS) Should Contact Wolf Haldenstein Immediately Shareholders who lost money in Gossamer Bio, Inc (NASDAQ: GOSS) Should Contact Wolf...
PR Newswire·4d ago
Deadline Alert: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 1, 2026deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise...
Business Wire·5d ago
Deadline Approaching: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcomingJune 1, 2026deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchasedGossamer Bio, Inc. (Gossamer...
Business Wire·6d ago
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Overstated Trial Prospects: Levi & Korsinsky
'We firmly believe that we have accomplished this patient selection goal.' That was the promise. The reality: a Phase 3 trial that failed its primary endpoint, and shareholders who lost over 80% of...
Business Wire·7d ago
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class Action
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or...
Business Wire·7d ago
GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit -- The Gross Law Firm
GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit -- The Gross Law Firm GOSS Shareholder Alert: Investors With Losses May Seek...
PR Newswire·7d ago
Law Offices of Frank R. Cruz Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Gossamer Bio, Inc. (Gossamer or the Company...
Business Wire·8d ago
<
1
2
...
>